Pulmonology therapy focuses on patients with alpha-1 antitrypsin deficiency (AATD). These patients have reduced levels of alpha-1 antitrypsin (AAT) protein in their blood.
For additional resources, please click here.
| Product | Primary Uses | Product Description |
| ARALAST NP [Alpha1-Proteinase Inhibitor (Human)] (US) | Chronic augmentation therapy in patients having congenital deficiency of A1PI with clinically evident emphysema | Sterile, stable, lyophilized preparation of purified alpha1-proteinase inhibitor (∝1Pl), also known as alpha1-antitrypsin (AAT) |
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
Read More [+]
Please consult your local approved product labeling for prescribing information. Please note that not all products are licensed in all countries.